Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver
NICE guidance
Summary (source: NICE)
Reference: HTG720
Type: NICE guidance
Published: 16 May 2024
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver is nice guidance HTG720, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 16 May 2024. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.